FRCR Part 2A · Cardiothoracic · Cardiac CT

Cardiac CT: High-Yield Concepts for FRCR Part 2A

Published by FRCR AI · AI-assisted educational content

Created and overseen by Dr. Tan Min On, Radiologist — MedNex Pte. Ltd.

Published · Updated

Cardiac CT: High-Yield Concepts for FRCR Part 2A

Cardiac CT: High-Yield Concepts for FRCR Part 2A

Cardiac CT has evolved from a basic anatomical screening tool into a sophisticated diagnostic framework capable of assessing plaque composition, hemodynamic significance, and myocardial perfusion. For the FRCR Part 2A candidate, understanding the transition from purely anatomical assessment to functional and plaque-based evaluation is critical. The current gold standard for reporting is the CAD-RADS 2.0 system, released in 2022/2023, which fundamentally shifts how coronary artery disease (CAD) is communicated.

1. The CAD-RADS 2.0 Framework

The CAD-RADS 2.0 reporting system replaces the deprecated 2016 framework. It provides a standardized nomenclature for coronary computed tomography angiography (CCTA) findings, integrating stenosis grading (0-5) with essential modifiers that reflect the functional and structural complexity of the plaque. This system is designed to provide clear, actionable recommendations for clinical management.

Exam tip: Modern SBA vignettes will likely feature reports incorporating the 'P' (Plaque) descriptor and 'I' (Ischemia) modifier. Candidates must demonstrate an understanding of how these parameters influence the decision to proceed to invasive coronary angiography (ICA) versus medical management.

2. Plaque Burden Assessment (P-Descriptor)

A critical update in CAD-RADS 2.0 is the mandatory inclusion of the Plaque Burden descriptor (P1–P4). This replaces more subjective or vague descriptions of disease extent. By quantifying the total atherosclerotic disease burden across the coronary tree, clinicians can better stratify patient risk regardless of the presence of a single severe stenosis.

Exam tip: P1 is defined as mild, P2 as moderate, P3 as severe, and P4 as extensive. These categories correlate with the patient’s overall risk profile and the intensity of recommended preventive medical therapy (e.g., statin therapy and lifestyle intervention).

3. Functional Modifiers: I, E, and V

CAD-RADS 2.0 utilizes specific modifiers to provide context to the anatomical findings. The 'I' modifier is vital for indicating the results of functional testing (e.g., CT-FFR or stress CTP). The 'E' modifier addresses non-atherosclerotic findings, such as coronary anomalies or spontaneous coronary artery dissection (SCAD). The 'V' modifier highlights vulnerable plaque characteristics.

ModifierDefinitionPurpose
IIschemiaIndicates functional assessment result (e.g., I+ for ischemia, I- for no ischemia)
EExceptionFlags non-atherosclerotic findings like dissection, anomalies, or fistulae
VVulnerableIdentifies high-risk plaque features (e.g., positive remodeling or low attenuation)

4. Integration of CT-FFR and CTP

Computed Tomography Fractional Flow Reserve (CT-FFR) and Computed Tomography Perfusion (CTP) are no longer experimental; they are now established tools for managing stable chest pain. They address the 'anatomical-functional mismatch' where a moderate stenosis may not be hemodynamically significant. These modalities are typically reserved for patients with intermediate-grade stenoses (CAD-RADS 3 or 4) to guide whether revascularization is necessary, thereby reducing unnecessary ICA procedures.

5. Standardized Nomenclature and High-Risk Features

The 2023 SCCT update provides a unified language for reporting. It is essential to recognize the features of high-risk (vulnerable) plaque, which are associated with acute coronary syndrome risk. These include:

  • Low attenuation plaque (typically ≤ 30 HU).
  • The 'napkin-ring sign' (a central core of low attenuation surrounded by higher attenuation).
  • Positive remodeling (the vessel diameter is larger at the site of the plaque compared to the proximal reference segment).
  • Spotty calcifications.

6. Clinical Context and Evolving Pathways

Candidates must appreciate the move toward CCTA as the first-line diagnostic investigation for stable chest pain in many guidelines, effectively replacing traditional exercise tolerance tests (ETT). This paradigm shift relies on the high negative predictive value of CCTA. When evaluating a case, always consider the patient's pre-test probability and the clinical question (e.g., exclusion of CAD vs. severity grading).

Key Takeaway: The FRCR candidate must move beyond simple percentage stenosis. CAD-RADS 2.0, with its mandatory P-burden grading and functional modifiers (I, E, V), is now the clinical and examination gold standard. Focus your preparation on how these new metrics dictate the transition from diagnosis to management.

Topics: cardiac ct · cad-rads 2.0 · coronary artery disease · ct-ffr · frcr